UAN · Cvr Partners, LP - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $180.05M | - | $163.55M | $168.56M | $142.87M | - | $125.20M | $132.90M | $127.67M | - |
| Cost of Revenue | $112.59M | - | $103.03M | $113.92M | $100.43M | - | $106.76M | $93.02M | $100.29M | - |
| Gross Profit | $67.45M | - | $60.52M | $54.63M | $42.44M | - | $18.45M | $39.88M | $27.38M | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | $9.03M | - | $9.17M | $8.03M | $7.89M | - | $7.45M | $6.31M | $7.31M | - |
| Total Operating Expenses | - | - | - | - | - | - | - | - | - | - |
| D&A | $19.96M | - | $19.96M | $20.86M | $18.04M | - | $24.73M | $20.04M | $19.29M | - |
| Operating Income | $57.65M | - | $50.64M | $46.32M | $34.59M | - | $11.00M | $33.56M | $20.06M | - |
| Interest Expense | - | - | - | - | - | - | - | - | - | - |
| Income Tax | $0 | - | $0 | $0 | $0 | - | $0 | $0 | ($25.0K) | - |
| Net Income | $49.91M | - | $43.07M | $38.77M | $27.09M | - | $3.81M | $26.22M | $12.58M | - |
| EPS - Basic | $4.72 | - | $4.08 | $3.67 | $2.56 | - | $0.36 | $2.48 | $1.19 | - |
| EPS - Diluted | $4.72 | - | $4.08 | $3.67 | $2.56 | - | $0.36 | $2.48 | $1.19 | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $128.09M | $69.24M | $156.18M | $114.40M | $121.78M | $90.86M | $110.54M | $47.52M | $64.62M | $45.28M |
| Accounts Receivable | $52.84M | $58.96M | $47.81M | $50.49M | $41.64M | $65.22M | $36.01M | $48.11M | $37.28M | $41.89M |
| Inventory | $88.31M | $82.68M | $81.85M | $73.86M | $80.39M | $75.58M | $75.30M | $80.61M | $72.40M | $69.17M |
| Accounts Payable | - | - | - | - | - | - | - | - | - | - |
| Current Assets | $271.20M | $213.87M | $288.55M | $242.20M | $247.11M | $233.54M | $226.63M | $183.63M | $182.47M | $165.87M |
| Total Assets | $1.02B | $969.46M | $1.04B | $998.00M | $1.01B | $1.02B | $986.63M | $959.45M | $972.22M | $975.33M |
| Current Liabilities | $98.57M | $96.77M | $107.73M | $70.27M | $98.94M | $111.35M | $105.18M | $59.50M | $79.53M | $75.47M |
| Long-term Debt | - | - | - | - | - | - | $547.71M | $547.57M | $547.44M | $547.31M |
| Total Liabilities | - | - | - | - | - | - | - | - | - | - |
| Stockholders' Equity | - | - | - | - | - | - | - | - | - | - |
| Retained Earnings | - | - | - | - | - | - | - | - | - | - |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $75.78M | - | - | - | $55.39M | - | - | - | $42.42M | - |
| Investing Cash Flow | ($12.84M) | - | - | - | ($5.81M) | - | - | - | ($5.32M) | - |
| Financing Cash Flow | ($4.10M) | - | - | - | ($18.67M) | - | - | - | ($17.76M) | - |
| CapEx | $17.05M | - | - | - | $9.87M | - | - | - | $8.10M | - |
| Free Cash Flow | $58.73M | - | - | - | $45.52M | - | - | - | $34.32M | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 37.5% | - | 37.0% | 32.4% | 29.7% | - | 14.7% | 30.0% | 21.4% | - |
| Operating margin | 32.0% | - | 31.0% | 27.5% | 24.2% | - | 8.8% | 25.3% | 15.7% | - |
| EBITDA margin | 43.1% | - | 43.2% | 39.9% | 36.8% | - | 28.5% | 40.3% | 30.8% | - |
| Net margin | 27.7% | - | 26.3% | 23.0% | 19.0% | - | 3.0% | 19.7% | 9.9% | - |
| Free cash flow margin | 32.6% | - | - | - | 31.9% | - | - | - | 26.9% | - |
| FCF / Net income | 1.18 | - | - | - | 1.68 | - | - | - | 2.73 | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | 5.0% | - | 5.6% | 4.8% | 5.5% | - | 5.9% | 4.7% | 5.7% | - |
| Effective tax rate | 0.0% | - | 0.0% | 0.0% | 0.0% | - | 0.0% | 0.0% | -0.2% | - |
| Return on assets | 4.9% | - | 4.2% | 3.9% | 2.7% | - | 0.4% | 2.7% | 1.3% | - |
| Return on equity | - | - | - | - | - | - | - | - | - | - |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 2.75 | 2.21 | 2.68 | 3.45 | 2.50 | 2.10 | 2.15 | 3.09 | 2.29 | 2.20 |
| Quick ratio | 1.86 | 1.36 | 1.92 | 2.40 | 1.69 | 1.42 | 1.44 | 1.73 | 1.38 | 1.28 |
| Cash ratio | 1.30 | 0.72 | 1.45 | 1.63 | 1.23 | 0.82 | 1.05 | 0.80 | 0.81 | 0.60 |
| Leverage | ||||||||||
| Debt / Equity | - | - | - | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | 0.56 | 0.57 | 0.56 | 0.56 |
| Debt / EBITDA | - | - | - | - | - | - | 15.33 | 10.22 | 13.91 | - |
| Interest coverage | - | - | - | - | - | - | - | - | - | - |
| Equity multiplier | - | - | - | - | - | - | - | - | - | - |
| Liabilities / Assets | - | - | - | - | - | - | - | - | - | - |
| Efficiency | ||||||||||
| Asset turnover | 0.18 | - | 0.16 | 0.17 | 0.14 | - | 0.13 | 0.14 | 0.13 | - |
| Inventory turnover | 1.27 | - | 1.26 | 1.54 | 1.25 | - | 1.42 | 1.15 | 1.39 | - |
| Days sales outstanding | 107d | - | 107d | 109d | 106d | - | 105d | 132d | 107d | - |
| Days inventory outstanding | 286d | - | 290d | 237d | 292d | - | 257d | 316d | 264d | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | 26.8x | - | 22.1x | 24.2x | 29.4x | - | 186.5x | 30.5x | 66.0x | - |
| P / B | - | - | - | - | - | - | - | - | - | - |
| P / S | 7.4x | - | 5.8x | 5.6x | 5.6x | - | 5.7x | 6.0x | 6.5x | - |
| EV / EBITDA | 15.6x | - | 11.3x | 12.3x | 12.8x | - | 32.1x | 24.2x | 33.4x | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 26.0% | - | 30.6% | 26.8% | 11.9% | - | -4.1% | -27.4% | -43.6% | - |
| Revenue CAGR (3y) | -7.3% | - | 1.5% | -11.6% | -13.8% | - | -4.7% | -1.3% | 28.0% | - |
| Revenue CAGR (5y) | 24.2% | - | 15.5% | 9.9% | 13.7% | - | 7.2% | -0.7% | 6.8% | - |
| Gross profit growth (YoY) | 58.9% | - | 228.1% | 37.0% | 55.0% | - | 8.4% | -46.2% | -76.6% | - |
| Operating income growth (YoY) | 66.7% | - | 360.5% | 38.0% | 72.4% | - | 35.1% | -49.7% | -81.7% | - |
| Net income growth (YoY) | 84.3% | - | 1031.4% | 47.9% | 115.3% | - | 420.8% | -56.2% | -87.7% | - |
| EPS growth (YoY) | 84.4% | - | 1033.3% | 48.0% | 115.1% | - | 414.3% | -56.2% | -87.7% | - |
| EPS CAGR (3y) | -21.2% | - | - | -30.9% | - | - | -52.1% | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | 29.0% | - | - | - | 32.6% | - | - | - | -73.0% | - |
| FCF CAGR (5y) | 21.1% | - | - | - | 16.7% | - | - | - | -6.7% | - |
| Book value growth (YoY) | - | - | - | - | - | - | - | - | - | - |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Business segments
$606.04M totalNitrogen Fertilizer Segment$606.04M · 100.0%
Product / service
$606.04M totalProduct UAN$374.32M · 61.8%
Product Ammonia$143.09M · 23.6%
Products Other$51.25M · 8.5%
Product Urea Products$37.38M · 6.2%
Peer comparison
Same SIC group: Agricultural Chemicals
Comparing CVR PARTNERS against the 5 most active filers in the same SIC group.
Dividends
$12.28/share trailing 12 months · +73.0% YoY
| Ex-date | Per share |
|---|---|
| May 11, 2026 | $4.0000 |
| Mar 2, 2026 | $0.3700 |
| Nov 10, 2025 | $4.0200 |
| Aug 11, 2025 | $3.8900 |
| May 12, 2025 | $2.2600 |
| Mar 3, 2025 | $1.7500 |
| Nov 8, 2024 | $1.1900 |
| Aug 12, 2024 | $1.9000 |
| May 10, 2024 | $1.9200 |
| Mar 1, 2024 | $1.6800 |
| Nov 10, 2023 | $1.5500 |
| Aug 11, 2023 | $4.1400 |
| May 12, 2023 | $10.4300 |
| Mar 3, 2023 | $10.5000 |
| Nov 10, 2022 | $1.7700 |
| Aug 11, 2022 | $10.0500 |
| May 12, 2022 | $2.2600 |
| Mar 4, 2022 | $5.2400 |
| Nov 10, 2021 | $2.9300 |
| Aug 12, 2021 | $1.7200 |
| Nov 1, 2019 | $0.7000 |
| Aug 2, 2019 | $1.4000 |
| May 3, 2019 | $0.7000 |
| Mar 1, 2019 | $1.2000 |